PIONEERING HEALTHCARE FOR THE HUMAN RACE

China, 21 November 2019: Mundipharma strongly rejects the allegations in the Associated Press story dated 20 November, that Mundipharma acted in an improper or illegal manner.  Mundipharma is...

We are reviewing the claims presented in the Associated Press (AP) story dated 20 November 2019. This includes assessing the accuracy and relevance of the documents on which they base their claims. ...

VivaGel® BV has received a further regulatory approval in Asia Mundipharma will market VivaGel® BV under their brand name BETADINETM BV Gel in Asian countries This additional approval...

VivaGel® BV has received regulatory approval in South East Asian countries, with further registration reviews at an advanced stage throughout the region Mundipharma will market VivaGel® BV...

Novartis and Mundipharma have signed an agreement for Mundipharma to market, sell and distribute Novartis medicines in the general ophthalmology disease area, including medicines for glaucoma and...

BETADINE® Celebrates the Golden Jubilee of the First Moon Landing The antiseptic chosen by NASA ensured moon germs were not brought back to earth Singapore, 19 July 2019 – Across the globe,...